Rev Esp Quimioter 2022; 35(1):76-79
Mycoplasma genitalium and sexually transmitted infections: evidences and figures in a tertiary hospital
GLORIA MARTÍN-SACO, ALEXANDER TRISTANCHO, ANTONINA ARIAS, ISABEL FERRER, ANA MILAGRO, JUAN M. GARCÍA-LECHUZ
Published: 17 December 2021
Introduction. Mycoplasma genitalium is an emerging cause of sexually transmitted infections (STIs) and has been implicated in non-gonococcal urethritis in men and cervicitis in woman. The aim of this study is determinate the incidence and pathogenicity of M. genitalium within the diagnosis of STIs detected from clinical samples in a third level hospital.
Material and methods. A total of 8,473 samples from endocervix, urethra, vagina, rectum and others were processed applying Allpex STI Essential Assay. More than 190 records were reviewed to determinate M. genitalium pathogenicity.
Results. M. genitalium was detected in a rate 2.8%. Co-infections were detected in 20% of the patients.
Conclusions. M. genitalium is considered a STI emerging pathogen thanks to the renewal of multiplex-PCR tests although with a low incidence in our approach. Emerging from our experience and the institutional recommendations both detection of acid nucleic techniques (NAATs) and gonococcal culture might be implemented accurately and coexist to adequate prescriptions.
Rev Esp Quimioter 2022; 35(1):76-79 [Full-text PDF]